Feasibility and dosimetry studies for 18F-NOS as a potential PET radiopharmaceutical for inducible nitric oxide synthase in humans

Journal of Nuclear Medicine

Volumn 53, Issue 6, 2012, Pages 994-1001

  Herrero, Pilar ^a   Laforest, Richard ^a   Shoghi, Kooresh ^a   Zhou, Dong ^a   Ewald, Gregory ^b   Pfeifer, John ^b   Duncavage, Eric ^b   Krupp, Kitty ^a   Mach, Robert ^a   Gropler, Robert J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac; Molecular imaging; Positron emission tomography

Indexed keywords

2 AMINO 4 METHYLPYRIDINE F 18; INDUCIBLE NITRIC OXIDE SYNTHASE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLADDER WALL; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG UPTAKE; FEASIBILITY STUDY; FEMALE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEAN RESIDENCE TIME; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; TISSUE LEVEL; WHOLE BODY IMAGING;

ADULT; FEASIBILITY STUDIES; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 84861914393     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.088518     Document Type: Article

References (28)

1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593-615. (Pubitemid 32735142)
2. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev. 2005;57:217-252. (Pubitemid 41043885)
3. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem. 1993;268:12231-12234. (Pubitemid 23182366)
4. Kaneki M, Shimizu N, Yamada D, Chang K. Nitrosative stress and pathogenesis of insulin resistance. Antioxid Redox Signal. 2007;9:319-329. (Pubitemid 46145980)
5. Koch A, Burgschweiger A, Herpel E, et al. Inducible NO synthase expression in endomyocardial biopsies after heart transplantation in relation to the postoperative course. Eur J Cardiothorac Surg. 2007;32:639-643. (Pubitemid 47362716)
6. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: The two sides of the same coin. Semin Cancer Biol. 2005;15:277-289. (Pubitemid 41058773)
7. Smith KJ, Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 2002;1:232-241. (Pubitemid 37159185)
8. Fitzpatrick B, Mehibel M, Cowen RL, Stratford IJ. iNOS as a therapeutic target for treatment of human tumors. Nitric Oxide. 2008;19:217-224.
9. McCarthy HO, Coulter JA, Robson T, Hirst DG. Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions. J Pharm Pharmacol. 2008;60:999-1017.
10. Pannu R, Singh I. Pharmacological strategies for the regulation of inducible nitric oxide synthase: Neurodegenerative versus neuroprotective mechanisms. Neurochem Int. 2006;49:170-182. (Pubitemid 43867075)
11. 18F]6-(2-fluoropropyl)-4-methyl- pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase. J Med Chem. 2009;52:2443-2453.
12. Lewis NP, Tsao PS, Rickenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation. 1996;93:720-729. (Pubitemid 26052458)
13. Comtat C, Kinahan PE, Defrise M, Michel C, Townsend DW. Fast reconstruction of 3D-PET data with accurate statistical modeling. IEEE Trans Nucl Sci. 1998;45:1083-1089. (Pubitemid 128739164)
14. Hebert T, Leahy RM. Fast methods for including attenuation correction in the EM algorithm. IEEE Trans Nucl Sci. 1990;37:754-758. (Pubitemid 20713964)
15. Hudson HM, Larkin LS. Accelarated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13:601-609.
16. Gropler RJ, Siegel BA, Sampathkumaran K, et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol. 1992;19:989-997.
17. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol. 1989;14:639-652. (Pubitemid 19229339)
18. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840. (Pubitemid 26292051)
19. Bailer AJ. Testing for the equality of area under the curves when using destructive measurement techniques. J Pharmacokinet Biopharm. 1988;16:303-309.
20. Weiss M. The relevance of residence time theory to pharmacokinetics. Eur J Clin Pharmacol. 1992;43:571-579.
21. Thomas SR, Stabin MG, Chen CT, Samaratunga RC. MIRD pamphlet no. 14 revised: a dynamic urinary bladder model for radiation dose calculations. J Nucl Med. 1999;40:102S-123S. (Pubitemid 29171815)
22. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: The Second-Generation Personal Computer Software for Internal Dose Assessment in Nuclear Medicine. J Nucl Med. 2005;46:1023-1027. (Pubitemid 43733519)
23. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection. J Heart Lung Transplant. 2005;24:1710-1720. (Pubitemid 41641841)
24. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169-2180. (Pubitemid 46693756)
25. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol. 2001;33:1897-1918. (Pubitemid 33097270)
26. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006;6:521-534. (Pubitemid 43980541)
27. Lüth HJ, Holzer M, Gärtner U, Staufenbiel M, Arendt T. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res. 2001;913:57-67. (Pubitemid 32786931)
28. International Commission on Radiological Protection (ICRP). Radiation Dose to Patients from Radiopharmaceuticals: ICRP Publication 80, in Addendum to ICRP Publication 53. Oxford U.K.: Pergamon Press; 1999.